TA Associates Is Said to Delay OmniActive Sale on Tariff Concern

TA Associates is delaying a planned sale of its majority stake in India’s OmniActive Health Technologies Ltd. due to uncertainty about the impact of US tariffs on the business, according to people familiar with the matter.

The private equity firm may now wait until at least 2026 before launching a sale process for the dietary supplements, food and drinks maker, the people said, asking not to be identified because the information is private.